Code | CSB-RA694283A0HU |
Size | US$210 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
Application | Recommended Dilution |
---|---|
IHC | 1:50-1:200 |
IF | 1:50-1:200 |
The KAT8 recombinant monoclonal antibody was created using genetic engineering methods to clone and express the gene responsible for producing the KAT8 monoclonal antibody. To generate the KAT8 monoclonal antibody, a synthesized peptide from human KAT8 protein was used as the immunogen. The obtained KAT8 recombinant monoclonal antibody was purified using affinity chromatography to ensure its high purity and specificity for the KAT8 protein. It has been extensively validated for use in human samples, and three applications, including ELISA, IHC, and IF, have been conducted to verify the quality and specificity of the KAT8 recombinant monoclonal antibody.
KAT8, also known as MYST1, is a histone acetyltransferase (HAT) protein that functions as a transcriptional coactivator. It is involved in the regulation of various cellular processes, such as cell cycle progression, DNA damage response, apoptosis, and development. KAT8 specifically acetylates lysine 16 on histone H4, which is associated with gene activation and chromatin remodeling. Additionally, KAT8 has been implicated in the regulation of gene expression through interactions with transcription factors and other chromatin-modifying enzymes. Dysfunction of KAT8 has been linked to various diseases, including cancer and neurodegenerative disorders.
There are currently no reviews for this product.